Immunizations Updates in Family Medicine 2017
|
|
- Gwendoline Nelson
- 6 years ago
- Views:
Transcription
1 Immunizations Updates in Family Medicine 2017 Joyce Sanchez, MD, FACP Assistant Professor of Medicine Division of Infectious Diseases 2017 MFMER slide-1
2 No disclosures 2017 MFMER slide-2
3 Learning Objectives Describe updates in the following vaccinations Pneumococcal vaccine Meningococcal vaccine MMR HPV Influenza Herpes Zoster 2017 MFMER slide-3
4 Case 1 A family medicine colleague who has been vaccinating patients 65 years of age and older with PPSV-23 asks you to explain the main benefit of PCV-13. Which of the following best describes the role of PCV-13 in elderly patients? A. It provides protection for multiple serogroups not covered by PPSV-23 B. It has been shown to decrease the incidence of pneumonia caused by the contained vaccine serotypes C. It has been shown to decrease mortality in this age group D. It has no role in patients who have received PPSV MFMER slide-4
5 PCV13 Vaccine and Pneumonia Bonten et al. N Engl J Med 2015; 372: MFMER slide-5
6 PCV-13 vaccine 46% efficacy in preventing pneumonia 75% efficacy in preventing invasive pneumococcal disease by vaccine-contained serotypes No different in mortality PPSV-23 has not shown similar reductions in those aged 65 and older 2017 MFMER slide-6
7 Case 2 A 65-year-old man who has hypertension and hyperlipidemia presents for his annual physical. He has felt well, and his only medication is lisinopril. He has never received the pneumococcal vaccine. The patient appears well. Temperature is 37.1 C (98.8 F), pulse rate is 71 per minute, respirations are 15 per minute, and blood pressure is 120/80 mm Hg. Oxygen saturation is 99% on room air. Physical examination reveals no gross abnormalities MFMER slide-7
8 Which of the following pneumococcal vaccine (PPSV-23 and/or PCV-13) immunization schedules should you recommend for this patient? A. PPSV-23 now and PCV-13 in one year B. PCV-13 and PPSV-23 now C. PCV-13 now and a second dose in one year D. PCV-13 now and PPSV-23 in one year E. PPSV-23 now and a second dose in 5 years 2017 MFMER slide-8
9 Pneumococcal Vaccine Schedule for Adults 65 years June 2015: ACIP proposed this interval change to 1 year June 2015: ACIP proposed this interval change to 1 year Tomczyk S. MMWR 2014; 63: MFMER slide-9
10 Pneumococcal vaccine schedule Routine vaccination with PCV-13 and PPSV-23 for all persons 65 years PPSV23 VACCINE HISTORY 0 PCV13 ALL ADULTS AGED 65 years * PPSV23 12 months later** PPSV23 age 65 years PCV13 1 year after PPSV23 PPSV23 age <65 years PCV13 1 year after PPSV23 PPSV23 12 months later*** * Without immunocompromising conditions ** PPSV can be given later than 12 months after PCV13 if this window is missed *** A one-time booster dose of PPSV23 should be administered 5 years after the first PPSV23 dose 2017 MFMER slide-10
11 Case 3 A 19 year old man is recently diagnosed with nephrotic syndrome of uncertain etiology. He has received all his childhood vaccines. He has no allergies or other medical conditions. He presents to your clinic for a pre-employment physical and preventive health maintenance MFMER slide-11
12 Which of the following is the most appropriate recommendation regarding pneumococcal (PCV-13 and/or PPSV-23) vaccination for this patient? A. PCV-13 alone B. PPSV-23 alone C. PCV-13 followed by PPSV-23 after at least 8 weeks D. PCV-13 followed by PPSV-23 after at least 1 year E. PPSV-23 followed by PCV-13 after at least 1 year 2017 MFMER slide-12
13 Pneumococcal vaccination PPSV23 should be administered at least 1 yr after PCV13, except among adults with predisposing condition), for whom the interval should be at least 8 wks Adults yrs should get PPSV23 chronic heart disease (including CHF and cardiomyopathies, excluding HTN), chronic lung disease, chronic liver disease, alcoholism, or diabetes mellitus, or who smoke cigarettes: administer 2017 MFMER slide-13
14 Adults yrs 1= chronic heart/lung disease, DM, alcoholism, cirrhosis, asthma, cigarette smoking 2=cochlear implant, CSF leak 3=Immunocompromised or asplenia Congenital/acquired immunodeficiency HIV CKD; nephrotic syndrome Malignancy Solid organ transplant Iatrogenic immunosuppression 2017 MFMER slide-14
15 Case 4 In which of the following situations is the use of meningococcal group B vaccine most appropriate? A. A college outbreak to eliminate the carrier state B. A traveler to the meningococcal "belt" in equatorial Africa C. A patient with terminal complement deficiency D. All healthcare workers 2017 MFMER slide-15
16 MenACWY-D (Menactra) Two serogroup B meningococcal vaccines have been licensed by the FDA Recommended for people 10 years who are at increased risk for serogroup B meningococcal infections: Serogroup B meningococcal disease outbreak Damaged or absent spleen Persistent complement component deficiency Patients on eculizumab Microbiologists who work with N. meningitidis 2017 MFMER slide-16
17 Serogroup B Meningococcal Vaccines MFMER slide-17
18 Case 5 A 30-year-old Muslim man is going on a pilgrimage to Mecca (including the Hajj) with his father. He thinks he needs some vaccines before he goes. He was born and raised in Minnesota and received all childhood vaccinations. He has never traveled outside the US before MFMER slide-18
19 Regarding meningococcal vaccination. What do you recommend? A. MenACWY-D (Menactra) B. Serogroup B meningococcal vaccine C. A and B D. No meningococcal vaccine needed E. Tell me where I can found out 2017 MFMER slide-19
20 Meningitis risk in travelers Meningitis Belt Greatest risk: dry season (Dec. - June) Risk of travelers: 0.4/100,000 Hajj pilgrimage to Saudi Arabia associated with outbreaks of meningococcus group A (not group B) Hajj pilgrims must have had the meningococcal vaccine 3 years and 10 days before arriving in Saudi Arabia MFMER slide-20
21 2017 MFMER slide-21
22 Case 6 For which of the following groups is a second MMR vaccination recommended? A. Travelers to Tanzania B. All adults older than 19 years of age C. Pregnant women who are in the third trimester D. Persons who are immunosuppressed as a result of taking chronic corticosteroids E. All adults 65 years of age and older 2017 MFMER slide-22
23 MMR Vaccination Children need 2 doses of MMR vaccine: 1 st dose age months, 2 nd dose age 4-6 years Teens and adults should be up to, especially: Students at post-high school educational institutions International travelers Healthcare professionals Women of childbearing age who are not pregnant People who care for/around immunocompromised HIV infected without severe immunosuppression Pregnancy, immunosuppression: relative contraindications 2017 MFMER slide-23
24 Case 7 A 9 year old girl with a history of ADD presents for her yearly physical with her mother. Her mother regretfully reports that her daughter was sexually molested by a close male family member 2 months ago. She underwent an emergency evaluation at the time of the incident. The offender is now incarcerated after a formal investigation MFMER slide-24
25 What do you recommend regarding HPV vaccination in this child? A. Vaccinate now and give booster in 6 months B. Vaccinate now with subsequent boosters in 1 month and 6 months C. At age 11, give 2 shots 6 months apart D. At age 11, give 3 shots over 6 months E. At age 14, 3 shots over 6 months 2017 MFMER slide-25
26 HPV Vaccine Children starting at age 9 with a history of sexual abuse All children years: 2 shots 6-12 months apart Children 14 years: 3 shots over 6 months All young men through age 21 The following through age 26 Women MSM (including gay or bisexual) Transgender Immunocompromising conditions (including HIV) 2017 MFMER slide-26
27 HPV Vaccine MFMER slide-27
28 Case 8 A 28 year old woman of 20 weeks gestation with her second child presents to your clinic in February. She is healthy and has no acute concerns. She has never received the influenza vaccine. She completed her childhood DTaP series and received Tdap vaccination at the time of delivery of her first child three years ago. She has no known allergies MFMER slide-28
29 Regarding vaccinations, which of the following should you advise? A. Influenza vaccination now B. Tdap vaccination now C. Tdap and influenza vaccination now D. Tdap and influenza vaccination shortly after delivery E. Influenza vaccination now, and routine Td 10 years after her previous Tdap dose 2017 MFMER slide-29
30 Tdap and Pregnancy CDC recommends Tdap with each pregnancy after 20 weeks gestation regardless of previous vaccination history Provides maternal antibodies to the infants during the time that they are most vulnerable to disease (first 2 months) 2017 MFMER slide-30
31 Influenza Vaccine (inactivated) Everyone 6 months old Especially pregnant women Contraindications: Severe allergic reaction to vaccine or vaccine component (including egg protein) Precautions: Moderate or severe acute illness Guillain-Barré Syndrome within 6 weeks of previous flu vaccine 2017 MFMER slide-31
32 Live attenuated Influenza Vaccine In season: Not effective (3%)!!! ACIP and CDCrecommendations LAIV4 should not be used for the influenza season MFMER slide-32
33 Herpes Zoster in Immunocompromised Current live-attenuated vaccine contraindicated in immunocompromised Nearly 3 fold higher risk of zoster in 42 days after vaccine Subunit vaccine effective in older adults, phase 3 study. Approval expected later in MFMER slide-33
34 Thank you! 2017 MFMER slide-34
35 Ebola Vaccine 2017 MFMER slide-35
36 Zika Vaccine Low variation between strains vaccine against one strain could possibly protect against other strains Several approaches being studied Inactivated Live attenuated Subunit DNA Vector-based 2017 MFMER slide-36
37 Zika Vaccines in Development Institute Vaccine Platform(s) Status Inovio DNA Vaccine In clinical trials in PR NIH Bharat DNA Vaccine Live VZV recombinant Live attenuated ZIKV Purified inactivated virus VLP expressing polyprotein In clinical trials Preclinical/animal studies NewLink Purified inactivated virus Preclinical/animal studies Novavax Protein nanoparticle vaccine Preclinical/animal studies Replikins Synthetic peptide vaccine Preclinical/animal studies Pharos Biologicals DNA vaccine Preclinical/animal studies 2017 MFMER slide-37
38 Zika Vaccines in Development Institute Vaccine Platform(s) Status Bio-Manguinhos Butantan US CDC Purified inactivated virus YF17DD chimera VLP DNA Dengue recombinant Purified Inactivated virus VLP expressing ZIKV DNA Live attenuated recombinant Early stage research Early stage research Early stage research CureVac Thermostabile mrna-based vaccine Early stage research Geovax Live MVA recombinant Early stage research GSK Self-amplifying mrna platform Early stage research Hawaii Biotech Alhydrogel + recombinant protein Early stage research Oxford University Live adenovirus recomninant Early stage research Protein Sciences Recombinant E protein Early stage research Sanofi YF17D chimera Early stage research Sementis Live poxvirus recombinant Early stage research Themis Bioscience Live measles recombinant Early stage research Valneva Purified inactivated virus Early stage research Mayo Vaccine Research Group HLA-presented, natuarally processed and presented ZIKV peptides packaged with biodegradable nanoparticles Early stage research 2017 MFMER slide-38
Series of 2 doses, 6-12 months apart. One dose is 720 Elu/0.5ml (GSK) or 25 u/0.5 ml (Merck)
UTAH PREVENTIVE CARE RECOMMENDATIONS Adult - Ages 19 and Above IMMUNIZATIONS CONTENTS: General Instructions Hepatitis A Hepatitis B Human Papilloma Virus Influenza Meningococcal A, C, Y, W (MCV4) Meningococcal
More informationVaccinations for Adults
Case: Vaccinations for Adults Lisa Winston, MD University of California, San Francisco San Francisco General Hospital A 30-year old healthy woman comes for a routine visit. She is recently married and
More informationUPDATE ON IMMUNIZATION GUIDELINES AND PRACTICES
DISCLOSURES UPDATE ON IMMUNIZATION GUIDELINES AND PRACTICES Nothing to disclose Kylie Mueller, Pharm.D., BCPS Clinical Specialist, Infectious Diseases Spartanburg Regional Medical Center LEARNING OBJECTIVES
More information3 rd dose. 3 rd or 4 th dose, see footnote 5. see footnote 13. for certain high-risk groups
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years 2013. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations must be read
More informationImmunization Update: New CDC Recommendations. Blaise L. Congeni M.D. 2012
Immunization Update: New CDC Recommendations Blaise L. Congeni M.D. 2012 Polysaccharide Vaccines Vaccine Hib capsule polysaccharide PRP (polyribose ribitol phosphate) Not protective in infants
More information2/16/2015 IMMUNIZATION UPDATE Kelly Ridgway, RPh February 21, Today s Overview NEW RECOMMENDATIONS
IMMUNIZATION UPDATE 2015 Kelly Ridgway, RPh February 21, 2015 Today s Overview 1 2 3 4 5 6 Pneumococcal Vaccine Recommendations Meningococcal Vaccine Recommendations HPV Vaccine Recommendations Patient
More informationNOTE: The above recommendations must be read along with the footnotes of this schedule.
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years 2013. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations must be read
More informationImmunization Guidelines for the Use of State Supplied Vaccine April 18, 2013
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationAdult Immunization Update 2015
Adult Immunization Update 2015 Objectives Upon completion of this session, the pharmacist should be able to: Compare and contrast previous versions of the ACIP immunization schedules with the most recent
More informationVaccines, Not Just for Babies
Vaccines, Not Just for Babies Meg Fisher, MD Medical Director Disclosures I have no relevant financial relationships with the manufacturers of any commercial products or commercial services discussed in
More informationImmunization Guidelines for the Use of State Supplied Vaccine May 17, 2015
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationNOTE: The above recommendations must be read along with the footnotes of this schedule.
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years United States, 2014. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations
More information2017 Vaccination Update
2017 Vaccination Update NATHAN BOONSTRA, MD General Pediatrician, Blank Pediatric Clinic TODAY S OBJECTIVES Review the latest recommendations for immunizations, including HPV Meningococcal vaccines Influenza
More informationThese slides are the property of the presenter. Do not duplicate without express written consent.
Cancer Survivorship Protecting Against Vaccine Preventable Diseases Heidi Loynes BSN, RN Immunization Nurse Educator Michigan Department of health and Human Services (MDHHS) loynesh@michigan.gov Are Vaccine-Preventable
More information11/17/2013 THE WHO, WHAT, WHEN, AND WHY OF ADULT VACCINATIONS. Pneumococcal Vaccines for Adults (PPV) Pneumococcal Vaccines
THE WHO, WHAT, WHEN, AND WHY OF ADULT VACCINATIONS CAROL A. KAUFFMAN, MD VA ANN ARBOR HEALTHCARE SYSTEM UNIVERSITY OF MICHIGAN Will discuss: bacterial vaccines made of toxoids or polysaccharide capsular
More information7/13/2016. Immunization Update Disclosures. Objectives. No financial disclosures to report
Immunization Update 2016 Courtney A. Robertson, PharmD Clinical Assistant Professor University of Louisiana at Monroe School of Pharmacy Disclosures No financial disclosures to report Objectives Pharmacists
More informationVaccines for infants- What has happened in the last year?
Vaccines for infants- What has happened in the last year? MARK H. SAWYER UCSD SCHOOL OF MEDICINE RADY CHILDREN S HOSPITAL SAN DIEGO Lots has happened and it can be a little confusing Infants used to require
More informationKatherine Julian, MD July 1, Vaccines Generally Available in the U.S. U.S.
Katherine Julian, MD July 1, 2008 Vaccines Generally Available in the U.S. Vaccines Generally Available in the U.S. Vaccines for Special Populations Plague Tularemia Smallpox Anthrax Botulism Tuberculosis
More informationAndrew Kroger, MD, MPH National Center for Immunization and Respiratory Diseases MCH & Immunization Conference Anchorage, AK September 28, 2010
2010 Immunization Update Andrew Kroger, MD, MPH National Center for Immunization and Respiratory Diseases MCH & Immunization Conference Anchorage, AK September 28, 2010 Disclosures No financial conflict
More informationStreptococcus pneumoniae CDC
Streptococcus pneumoniae CDC Pneumococcal Disease Infection caused by the bacteria, Streptococcus pneumoniae» otitis media 20 million office visits (28-55% Strep)» pneumonia 175,000 cases annually» meningitis
More informationImmunization Update Tamara Sheffield, MD, MPA, MPH
Immunization Update 2015 Tamara Sheffield, MD, MPA, MPH Disclosure I do not have any relevant financial relationships with any commercial interests I am a Medical Director employed by Intermountain Healthcare
More informationPreteen and teen vaccines: what to do with the recent recommendations
Preteen and teen vaccines: what to do with the recent recommendations MARK H. SAWYER UCSD SCHOOL OF MEDICINE RADY CHILDREN S HOSPITAL SAN DIEGO Continuing Education The Illinois Chapter, American Academy
More information2013 Adult Immunization Update. David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle
2013 Adult Immunization Update David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle Adult Immunization Update Pertussis Vaccine Influenza Vaccine Zoster
More information2/29/2016. Disclosures. Learning Objectives
Cody Sasek, MPAS, PA C Assistant Professor and Academic Director Physician Assistant Education University of Nebraska Medical Center Omaha, NE Disclosures It is the policy of the University of Nebraska
More informationRecommended Immunization Schedules for Persons Aged 0 Through 18 Years UNITED STATES, 2016
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years UNITED STATES, 2016 This schedule includes recommendations in effect as of January 1, 2016. Any dose not administered at the recommended
More informationImmunizations June 5, Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR
Immunizations June 5, 2015 Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR Disclosures None Goals Understand basic public health impact of immunization Recognize types
More information21 st Century Vaccine Challenges
21 st Century Vaccine Challenges Presentation by Rosalyn Singleton MD, ANTHC Slides adapted from original powerpoint by: Carrie L. Byington, MD HA and Edna Benning Presidential Professor of Pediatrics
More informationSummary of Recommendations for Adult Immunization (Age 19 years and older) (Page 2 of 5)
Summary of Recommendations for Adult Immunization (Age 19 years and older) (Page 1 of 5) Influenza Inactivated Influenza (IIV*) or ID (intradermally) *includes recombinant influenza (RIV) Live attenuated
More informationHemagglutinin Neuraminidase
Evolving Vaccine Guidance: Influenza, Meningococcal & HPV Vaccines H. Cody Meissner, M.D. Professor of Pediatrics Tufts University School of Medicine Maine Chapter AAP Bar Harbor, Maine October 16, 2016
More information10/16/2018. Be Discuss. Describe. Discuss. Discuss 2018 ADULT IMMUNIZATION SCHEDULE INFLUENZA ADULT IMMUNIZATION UPDATE TRAINING OBJECTIVES FLUMIST
ADULT IMMUNIZATION UPDATE NORTH DAKOTA ACADEMY OF FAMILY PHYSICIANS NOVEMBER 10, 2018 Be Discuss Upon completion of the adult immunization training, participants will be able to: Discuss the general adult
More informationNeedle Facts: Immunization Update Mirada Wilhelm, PharmD Clinical Associate Professor SIUE School of Pharmacy
Needle Facts: Immunization Update 2015 Mirada Wilhelm, PharmD Clinical Associate Professor SIUE School of Pharmacy Objectives Pharmacists At the conclusion of this program, the pharmacist will be able
More informationPreventative Vaccines. Vaccines for Special Populations. Vaccinations for Adults: An Update. Vaccines Generally Available in the U.S.
Vaccinations for Adults: An Update Preventative Vaccines Need to be extremely safe Even greater issue as disease prevalence wanes or uncommon diseases targeted Lisa G. Winston, MD University of California,
More informationHIT ME WITH YOUR BEST SHOT: UPDATE ON IMMUNIZATIONS. Karen Hoang, PharmD Clinical Pharmacy Specialist, MTM Services UPMC Health Plan
HIT ME WITH YOUR BEST SHOT: UPDATE ON IMMUNIZATIONS Karen Hoang, PharmD Clinical Pharmacy Specialist, MTM Services UPMC Health Plan DISCLOSURES No financial or other conflicts to disclose LEARNING OBJECTIVES
More informationWhat DO the childhood immunization footnotes reveal? Questions and answers
What DO the childhood immunization footnotes reveal? Questions and answers Stanley E. Grogg, DO, FACOP, FAAP he Advisory Committee on Immunization Practices (ACIP) recommends the childhood vaccination
More informationAdult Vaccine Update. NB Internal Medicine Update, April 22 nd, 2016 Dan Smyth, MD, FRCPC, DTMH
Adult Vaccine Update NB Internal Medicine Update, April 22 nd, 2016 Dan Smyth, MD, FRCPC, DTMH Summary points: Canadian adults > 18 should be regularly assessed to ensure recommended vaccinations are up
More informationKeeping up with immunizations for adults
MEDICAL GRAND ROUNDS CME CREDIT EDUCATIONAL OBJECTIVE: Readers will vaccinate their patients according to guidelines from the US Centers for Disease Control and Prevention CRAIG NIELSEN, MD Associate Professor,
More information! Need to be extremely safe Even greater issue as disease prevalence wanes or uncommon diseases targeted
Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital! Need to be extremely safe Even greater issue as disease prevalence wanes or uncommon diseases targeted! Traditionally
More informationImmunization Guidelines For the Use of State Supplied Vaccine July 1, 2011
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationVaccines and Adults: Our Collective Challenge Webinar
Vaccines and Adults: Our Collective Challenge Webinar Questions 1. What documentation would a pediatrician need to immunize adult parents to avoid some risk since they are non-patients of the practice
More informationRecommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2017
Caring for Our Children: National Health and Safety Performance Standards H Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2017 In February 2017, the Recommended Immunization
More informationACIP Meeting Update, New Recommendations and Pending Influenza Season
ACIP Meeting Update, New Recommendations and Pending Influenza Season February 17 th 2011 www.immunizetexas.com ACIP Upcoming Agenda and New Recommendations ACIP (February 23-24 th 2011) Topics for meeting
More informationUpdate on Vaccine Recommendations. Objectives. Childhood Immunization Schedule At the Turn of the Century. New Horizons in Pediatrics April 30, 2017
Centers for for Disease Disease Control Control and and Prevention Prevention National Center for Immunization and Respiratory Diseases Update on Vaccine Recommendations New Horizons in Pediatrics April
More informationVACCINES-WHAT HAS HAPPENED IN THE LAST YEAR. Mark H. Sawyer UCSD School of Medicine Rady Children s Hospital San Diego
VACCINES-WHAT HAS HAPPENED IN THE LAST YEAR Mark H. Sawyer UCSD School of Medicine Rady Children s Hospital San Diego LOTS HAS HAPPENED AND IT CAN BE A LITTLE CONFUSING Some people can get 2 doses of HPV
More informationWhat are the new active vaccine recommendations in the Canadian Immunization Guide?
154 CCDR 17 April 2014 Volume 40-8 https://doi.org/10.14745/ccdr.v40i08a03 1 What are the new active vaccine recommendations in the Canadian Immunization Guide? Warshawsky B 1 and Gemmill I 2 on behalf
More informationMeningococcal Update. Disclosure. Meningococal and Influenza Vaccines Update! Robert Wittler, MD Sept 12, 2014 KAAP Fall CME Meeting
1 Meningococal and Influenza Vaccines Update! Robert Wittler, MD Sept 12, 2014 KAAP Fall CME Meeting 2 Disclosure Speakers Bureau: Sanofi Pasteur Vaccines and Novartis! I do not intend to discuss an unapproved/
More information4/7/13. Vaccinations for Adults and Adolescents. Effect of Full Use of Adult Immunizations. General Vaccine Information
Vaccinations for Adults and Adolescents Nicholas A. Daniels, MD MPH Department of Medicine Professor of Clinical Medicine Declaration of full disclosure: No conflict of interest 2 Effect of Full Use of
More informationWhose Calling the Shots? - A 2019 Vaccine Update. Frank Bell Swedish Pediatric Infectious Disease Jan 2019
Whose Calling the Shots? - A 2019 Vaccine Update Frank Bell Swedish Pediatric Infectious Disease Jan 2019 2019 Vaccine Update Vaccines Meningococcal serogroup B HPV Pertussis Influenza Children with uncertain
More informationImmunizations to Reduce Disease H. Keipp Talbot, M.D., M.P.H.
Immunizations to Reduce Disease H. Keipp Talbot, M.D., M.P.H. Vanderbilt University School of Medicine 1 DISCLOSURES Financial Relationships with Relevant Commercial Interests Receive research funding
More informationAPEC Guidelines Immunizations
Pregnancy provides an excellent opportunity to enhance a woman s protection against disease and to provide protection to the neonate during the first 3 to 6 months of life. Women of childbearing age should
More informationVaccines for Primary Care Pneumococcal, Shingles, Pertussis
Vaccines for Primary Care Pneumococcal, Shingles, Pertussis Devang Patel, M.D. Assistant Professor Chief of Service, MICU ID Service University of Maryland School of Medicine Pneumococcal Vaccine Pneumococcal
More informationUpdate on Immunizations H. Keipp Talbot, M.D., M.P.H.
Update on Immunizations H. Keipp Talbot, M.D., M.P.H. Vanderbilt University Medical Center 1 DISCLOSURES Financial Relationships with Relevant Commercial Interests Receive research funding from Sanofi
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Preventative Vaccines
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital Preventative Vaccines Diseases/Pathogens
More informationHow to create a successful vaccine program
How to create a successful vaccine program Nothing to disclose and no conflicts of interest Vaccine Overview Vaccine Guidelines Purchasing: Supply, Manufacturers, Storage, Returns Reimbursement Codes
More informationRECOMMENDED IMMUNIZATIONS
Recommended Immunization Schedule for Persons Aged 0 Through 6 Years United States 2010 1 2 4 6 12 15 18 19 23 2 3 4 6 Vaccine Age Birth month months months months months months months months years years
More informationAdult Immunization Rates
Adult Immunization Rates California Immunization Coalition Summit May 5, 2014 Eileen Yamada, MD, MPH California Department of Public Health Immunization Branch Adult Immunization Rates California Data
More informationMOLINA HEALTHCARE OF TEXAS
MOLINA HEALTHCARE OF TEXAS Preventive Care Guidelines: Ages 21 and Older GUIDELINE Molina Healthcare of Texas has adopted Preventive Care Guidelines: Ages 21 and Older. The guideline was reviewed and adopted
More informationPolicy and Procedure Manual
Policy and Procedure Manual Medication Management MM.3-6 SUBJECT/TITLE: PURPOSE: DEFINITION: ADULT, INPATIENT PNEUMOCOCCAL AND SEASONAL INFLUENZA VACCINATION To ensure that adult inpatients who are candidates
More informationGuidelines for Vaccinating Pregnant Women
Guidelines for Vaccinating Pregnant Women April 2013 Guidelines for Vaccinating Pregnant Women Abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP) April 2013 Risk
More informationUpdate on Adult Immunization Strategies: Understanding the Current Recommendations
Update on Adult Immunization Strategies: Understanding the Current Recommendations EDWARD A. DOMINGUEZ, MD, FACP, FIDSA Medical Director, Organ Transplant Infectious Diseases Methodist Dallas Medical Center,
More informationGuidelines for Vaccinating Pregnant Women
Guidelines for Vaccinating Pregnant Women March 2012 Guidelines for Vaccinating Pregnant Women Abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP) MARCH 2012 Risk
More informationExpanding Practice of Pharmacist-Administered Immunizations for 2013
Expanding Practice of Pharmacist-Administered Immunizations for 2013 Rupal Mansukhani, PharmD Clinical Assistant Professor Rutgers University Piscataway, NJ Faculty Information Presenter: Rupal Mansukhani,
More informationImmunization Recommendations for College Students
May 2017 ACHA Guidelines Immunization Recommendations for College Students Immunizations offer safe and effective protection from vaccine-preventable diseases and outbreaks. The United States is experiencing
More informationImmunizations. Update Immunizations through Time. Learning Objectives. Presenter Disclosure Information. 10:30 11:45am. Immunization Update
10:30 11:45am Immunization Update SPEAKER John Russell, MD Presenter Disclosure Information The following relationships exist related to this presentation: John Russell, MD, serves on Speaker s Bureau
More informationSummary of Recommendations for Adult Immunization (Age 19 years and older) PAGE 1 OF 5
Summary of Recommendations for Adult Immunization (Age 19 years and older) PAGE 1 OF 5 Influenza Inactivated Influenza vaccine (IIV*) or ID (intradermally) * includes recombinant influenza vaccine (RIV3)
More informationImmunization Update 2013 Across the Lifespan
Immunization Update 2013 Across the Lifespan Andrew Kroger M.D., M.P.H. Medical Officer, Centers for Disease Control and Prevention New York State Association of County Health Officials (NYSACHO) New York
More informationJon Temte, MD/PhD Chair Wisconsin Council on Immunization Practices Professor of Family Medicine and Community Health
Jon Temte, MD/PhD Chair Wisconsin Council on Immunization Practices Professor of Family Medicine and Community Health University of Wisconsin School of Medicine and Public Health Grand Rounds September
More informationTDCJ OFFENDER IMMUNIZATION GUIDELINES
TDCJ OFFENDER IMMUNIZATION GUIDELINES B-14.07 Immunizations Attachment A VACCINE WHO GETS IT * WHEN THEY GET IT DOSE/ROUTE HPV Vaccine Females age 9 to 26 years if not previously vaccinated. On Intake
More information8/10/17 UPDATES IN ADOLESCENT AND ADULT IMMUNIZATIONS IN AMBULATORY CARE. Objectives. Background: ACIP. Membership. Focus
UPDATES IN ADOLESCENT AND ADULT IMMUNIZATIONS IN AMBULATORY CARE Laurie L. Duran, MSN, CRNP-Adult Texas Nurse Practitioners 29 th Annual Conference Sep 2017 Objectives 1. Use available resources to interpret
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Diseases/Pathogens with Vaccines for Special Populations.
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More information2017 Vaccine Preventable Disease Summary
2017 Vaccine Preventable Disease Summary Prepared 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata October 2018 2017 Summary of Vaccine Preventable Diseases in Ottawa County This is a detailed
More informationVACCINATION FOR WOMEN (ADOLESCENCE TO SENESCENCE)
VACCINATION FOR WOMEN (ADOLESCENCE TO SENESCENCE) Dr.T.K.SHAANTHY GUNASINGH M.D., D.G.O., FICOG PROFESSOR AND HEAD OF THE DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY PROGRAMME DIRECTOR CENTRE OF EXCELLENCE
More informationImmunizations: new and sometimes confusing recommendations MARK H. SAWYER, MD UCSD SCHOOL OF MEDICINE AND RADY CHILDREN S HOSPITAL SAN DIEGO
Immunizations: new and sometimes confusing recommendations MARK H. SAWYER, MD UCSD SCHOOL OF MEDICINE AND RADY CHILDREN S HOSPITAL SAN DIEGO Disclosures I have no financial disclosures related to this
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Outline vaccines to be covered
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationDeaths/yr Efficacy Use Prev Deaths/yr. Influenza 36,000 70% 60% 18,000. Pneumonia 40,000 60% 40% 20,000 HBV 6,000 90% 30% 4,000
Tetanus, Diptheria, Pertussis,! Measles, Mumps, Rubella, Varicella, HPV, Polio Meningococcus, Pneumococcus,! Influenza, Hepatitis B, Hepatitis A,! H influenza, Rabies, Typhoid,! Yellow Fever, Japanese
More informationVaccines in Immunocompromised hosts
Vaccines in Immunocompromised hosts Carlos del Rio, MD Emory Center for AIDS Research October 2013 Immunocompromised hosts Number has increased rapidly in the past decades Broad term that encompasses different
More informationNew Vaccine Schedules. Disclosure. Overview. Immunization Recommendations in Primary Care. Objectives Pharmacists. Objectives Pharmacy Technicians
Disclosure Immunization Recommendations in Primary Care I have nothing to disclose. Betsy Blake, PharmD, BCPS October 2017 Objectives Pharmacists Learning Objectives: At the completion of this activity,
More informationPlatforms. Adolescent Immunization Update and the 16 Year Old Platform. Advisory Committee on Immunization Practices (ACIP)
Adolescent Immunization Update and the 16 Year Old Platform William Atkinson, MD, MPH Associate Director for Immunization Education Immunization Action Coalition Advisory Committee on Immunization Practices
More informationTake advantage of preventive care to help manage your health
Take advantage of preventive care to help manage your health Preventing disease and detecting health issues at an early stage, if they occur, are important to living a healthy life. Following the recommended
More informationImmunization Update 2018
Immunization Update 2018 Keri Hurley-Kim, PharmD, MPH Assistant Professor, Department of Pharmacy Practice West Coast University School of Pharmacy Conflicts of Interest Keri Hurley-Kim declares no conflicts
More informationImmunization Update Disclosures. Candice Robinson, MD, MPH Medical Officer Immunization Services Division 5/12/2017
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Immunization Update 2017 Candice Robinson, MD, MPH Medical Officer Immunization Services Division Western
More informationGeneral Recommendations. General Best Practice Guidelines 9/10/2018. General Best Practice Guidelines for Immunization Part 1
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases General Best Practice Guidelines for Immunization Part 1 Chapter 2 September 2018 Photographs and images
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Diseases/Pathogens with Vaccines for Special Populations
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationImmunization Update 2017 Adult Clinical Learning Day. Tamara Sheffield, MD, MPA, MPH
Immunization Update 2017 Adult Clinical Learning Day Tamara Sheffield, MD, MPA, MPH Highlighted Topics Influenza Vaccine Errors 2 Dose HPV Community protection Tdap in pregnancy Meningococcal Future Recs
More informationOptima Health. Adult Health Maintenance Guidelines. Guideline History. Original Approve Date 04/93
Optima Health Adult Health Maintenance Guidelines Guideline History Original Approve Date 04/93 Review/ Revise Dates 8/94, 8/96, 6/97, 7/97, 10/98, 10/99, 5/00, 2/01,6/03, 06/05, 12/07,01/09, 1/10, 1/11,
More informationPoint/Counterpoint. Mia A. Taormina, DO, FACOI MarkAlain Dery, DO, FACOI
Point/Counterpoint Mia A. Taormina, DO, FACOI MarkAlain Dery, DO, FACOI It s Influenza Season A couple in their 40s comes to your clinic in early August and asks about influenza vaccine. It is being offered
More informationKenneth McCall, BSPharm, PharmD Associate Professor UNE
Kenneth McCall, BSPharm, PharmD Associate Professor UNE Objectives Discuss the gap between current rates and Healthy People 2020 goals for vaccinations. Categorize each of the CDC recommended flu vaccines
More information4/7/2017. Audrey Ofir, MD, MBA, FAAP University of Miami Miller School of Medicine Holtz Children Hospital
Audrey Ofir, MD, MBA, FAAP University of Miami Miller School of Medicine Holtz Children Hospital 1 9vHPV Tdap MCV LAIV HepB Children with Medical conditions 2 9vHPV vaccine HPV infection: Causes cervical,
More informationDeclarations. Objectives At the end of this presentation participants will be 7/25/2017. Dr. Mary Koslap Petraco has nothing to declare
Mary Koslap Petraco DNP, PNP BC, CPNP, FAANP Nurse Consultant Immunization Action Coalition Stony Brook University School of Nursing The Nurse Practitioner Association New York State 33 rd Annual Conference
More informationImmunization Resources for Pharmacists
Immunization Resources for Pharmacists TABLE OF CONTENTS Child / Teen Resources Screening Questionnaire Child/Teen... 3 Vaccine Schedule Age 0-6yrs... 5 Catch-Up Schedule 4mo-18yrs... 6 Vaccine Schedule
More informationDiclosures. Objectives 12/29/17
Kristy Brittain, PharmD, BCPS, CDE Associate Professor, MUSC College of Pharmacy Clinical Pharmacy Specialist, Medical University of SC Diclosures Kristy Brittain has no conflict of interest to report.
More informationVaccine Overview. Quick and Dirty Version
Vaccine Overview Quick and Dirty Version Key Points Random Facts Vaccine Schedule Types of Vaccines 7 Rules of vaccinations Vaccine Updates VACCINATIONS ARE IMPORTANT Never miss an opportunity to vaccinate!!!
More informationImmunizations Offered
Immunizations Offered Most vaccines commercially available in the United States are available at the health clinic. A partial list of available vaccines follows. For more information about specific vaccines
More informationImmunization Update Clark Kebodeaux, Pharm.D., BCACP
Immunization Update 2015 Clark Kebodeaux, Pharm.D., BCACP Objectives Describe the Advisory Committee on Immunization Practices (ACIP) recommendations and updates for 2014/2015 that guide current immunization
More informationAmerican Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida
Vaccine policy in the US Disease Prevention and Control: Vaccination Recommendations and Travel Medicine Update Lisa A. Klatka, DO, MS Medina County Health Department Medina, OH Manufacturers publish product
More informationACIP Recommendation Update. Mark H. Sawyer, MD UCSD School of Medicine Rady Children s Hospital San Diego
ACIP Recommendation Update Mark H. Sawyer, MD UCSD School of Medicine Rady Children s Hospital San Diego What has ACIP been up to lately? New Recommendations Tdap vaccination for each pregnancy Meningococcal
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Key Resource
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More information2018 AOCOPM Midyear Educational Conference San Antonio
FAQs $100 $200 $300 $400 $500 Current Concepts in Vaccination Vaccinepreventable diseases Special populations I m Leavin on a jet plane What s new? $100 $100 $100 $100 $200 $200 $200 $200 $300 $300 $300
More information16 November 2017 National Immunisation Advisory Committee Recommendations for the 2017/2018 Influenza Vaccination Campaign
16 November 2017 National Immunisation Advisory Committee Recommendations for the 2017/2018 Influenza Vaccination Campaign Please note the National Immunisation Advisory Committee (NIAC) has updated the
More informationThe National Immunisation Schedule Update and Current issues. Dr Brenda Corcoran National Immunisation Office.
The National Immunisation Schedule Update and Current issues Dr Brenda Corcoran National Immunisation Office : Dates vaccines introduced into the Irish immunisation schedule Vaccine 1937-1999 Date introduced
More information